George Laramore, MD, PhD, FACR, FASTRO

Locations of Practice

Overview

Dr. Laramore specializes in treating patients for salivary gland tumors, head and neck cancer, sarcoma of the soft tissue and bone, and genitourinary tumors particularly prostate cancer. Dr. Laramore practices at UWMC, Harborview, Seattle Children’s and Fred Hutchinson Cancer Center – Proton Therapy.

Patient Care Philosophy

“High-tech medicine can be adapted to the individual patient’s needs. I enjoy using the latest technological innovations in radiation oncology to design and carry out the optimal treatment for each patient. I am particularly interested in approaches that combine the benefits of radiotherapy with the use of chemotherapeutic agents or biological-response modifiers and in using genetic information to individualize patient treatment.”

Education and Training

College: Purdue University, West Lafayette, IN, 1965

Graduate School: PhD in Physics, University of Illinois, Urbana-Champaign, IL, 1969

Pre/Post-doctoral in physics: University of Illinois, funded by the National Science Foundation, 1970

Medical Education: University of Miami School of Medicine, Miami, FL, 1976

Residency: University of Washington School of Medicine, Radiation Oncology, Seattle, WA, 1978

Fellowship: American Cancer Society Clinical Fellow, 1980

Selected Publications from a Total of 258

Laramore GE. The evolving role of particle radiotherapy in the treatment of head and neck cancer. Med Res Arch 5(1): 1-17, 2017.

Ford E, Emery R, Huff D, Narayanan M, Schwartz J, Cao N, Meyer J, Rengan R, Zeng J, Sandison G, Laramore G, Mayr N. An image-guided precision proton radiation platform for preclinical in vivo research. Phys Med Biol 62: 43-58, 2017.

Divi V, Harris J, Harari PM, Cooper JS, McHugh J, Bell D, Sturgis EM, Cmelak AJ, Suntharalingam M, Raben D, Kikm H, Spencer SA, Laramore GE, Trotti A, Foote RL, Schultz C, Thorstad WL, Zhang QE, Le QT, Holsinger FC. Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234). Cancer 2016 [PMID: 27419843]

Hoppe BS, Tsai H, Larson G, Laramore GE, Vargas C, Tseng YD, Dunn M, McGee L, Cahlon O, Hartsell W. Proton therapy patterns-of-care and early outcomes for Hodgkin lymphoma: results from the Proton Collaborative Group Registry. Acta Oncol 55: 1378-1380, 2016. [PMID: 27579554]

Parvathaneni U, Sheti M, Berg D, Takagishi S, Laramore GE, Schmults CD, Jambusaria-Pahlajani A, Hess SD, Heyboer M, Liao JJ. Treatment recommendations among radiation oncologists in the treatment of cutaneous squamous cell carcinoma with perineural invasion. J Cancer Therapy 7: 824-835, 2016. http://dx.doi.org/10.4236/jct.2016.711082

Chapman TR, Laramore GE, Bowen SR, Orio PF. Neutron radiation therapy for advanced thyroid cancers. Adv Radiat Oncol 1: 148-156, 2016.

Davis C, Sikes J, Namaranian P, Laramore G, Dillon JK. Neutron beam radiation therapy: An overview of treatment and oral complications when treating salivary gland malignancies. J Oral Maxillofac Surg 74: 830-835, 2016.

Patel SA, Kusano AS, Truong A, Stelzer KJ, Laramore GE. Fast neutron radiotherapy in the treatment of malignant pleural mesothelioma. Am J Clin Oncol 38: 47-50, 2015.

Laramore GE, Zeng J, Fang LMC, Liao JJ, Russell KJ. Pathology review for patients with prostate cancer referred to the SCCA proton center. Int J Particle Ther 1: 878-883, 2015.

Gensheimer MF, Liao JJ, Garden AS, Laramore GE, Parvathaneni U. Submandibular gland-sparing radiation therapy for locally advanced oropharyngeal squamous cell carcinoma: patterns of failure and xerostomia outcomes. Radiat Oncol. 2014 Nov 26;9(1):255. [Epub ahead of print] PMID: 25424729.

Liao JJ, Parvathaneni U, Laramore GE, Thompson JA, Bhatia S, Futran ND, Bhrany AD, Hawes SE, Ladra M. Fast neutron radiotherapy for primary mucosal melanomas of the head and neck. Head Neck 36: 1162-1167, 2014.

Gensheimer MF, Rainey D, Douglas JG, Liao JJ, Laramore GE, Jian-Amadi A, Chow LQM, Koh WJ, Parvathaneni U. Neutron radiotherapy for adenoid cystic carcinoma of the lacrimal gland. Opthal Plast Reconst Surg 29(4): 256-260, 2013.